Tags: huntingtons disease | drug | trial | progression | halt

Huntington's Disease Drug Trial Shows Halt in Progression

Image: Huntington's Disease Drug Trial Shows Halt in Progression

Pope Francis leads a special audience with Huntington's disease sufferers and their families in May. (Sipa via AP)

By    |   Monday, 11 December 2017 11:04 AM

A Huntington's disease drug trial has made progress in halting the disease from progressing in patients, British researchers announced. The findings sent ripples of excitement through the medical community.

A team of scientists at the University College London found they could suppress the effects of the neurodegenerative disease by injecting an experimental drug into spinal fluid and lowering the levels of toxic proteins in the brain, the BBC News reported.

The trial was led by Professor Sarah Tabrizi of the school’s Institute of Neurology and involved 46 patients with early Huntington’s disease from across the UK, Germany and Canada.

“The results of this trial are of ground-breaking importance for Huntington’s disease patients and families,” said Tabrizi, per The Guardian. “This is probably the most significant moment in the history of Huntington’s since the gene [was isolated].”

The Huntington’s Disease Society for America describes the condition as “a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain.”

There has been no cure to the disease, which leads to the deterioration of a person’ physical and mental abilities and affects about 30,000 Americans, the society said.

For 51-year-old Peter Allen, who is in the early stages of the disease, the outcome has been bleak, BBC noted.

He has lost his mohter, uncle and grandmother to Huntington’s, and his sister and brother will develop the disease too, tests have revealed.

Amongst the three siblings there are eight children, each of whom stands a 50 percent chance of developing Huntington’s.

The new breakthrough trial could change things for their family.

"I'm the luckiest person in the world to be sitting here on the verge of having that,” Allen told BBC.

"Hopefully that will be made available to everybody, to my brothers and sisters and fundamentally my children."

© 2018 Newsmax. All rights reserved.

   
1Like our page
2Share
TheWire
British researchers announced that a Huntington's disease drug trial has made progress in halting the disease from progressing in patients, sending ripples of excitement through the medical community.
huntingtons disease, drug, trial, progression, halt
300
2017-04-11
Monday, 11 December 2017 11:04 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved